Tag: boneHealth

Articles

• How can we protect our daughters from breast cancer? - Childhood and puberty
• How can we protect our daughters from breast cancer? - Teenage years and young adulthood
• How important is Vitamin D before and after breast cancer diagnosis?
• What should breast cancer survivors eat during aromatase inhibitor treatment?

News

• Aromatase inhibitors can increase risk of early hip fracture in breast cancer survivors
• Bisphosphonates for treating osteoporosis may significantly reduce risk of breast cancer
• The bisphosphonate zoledronic acid might reduce breast cancer recurrence in postmenopausal women
• Vitamin D and calcium intakes influence risk of breast cancer
• Vitamin D deficiency promotes growth of breast cancer bone metastases
• Vitamin D supplementation counteracts side effect of treatment for bone metastases
• Women undergoing breast conserving treatment can have ongoing side effects

Foods

• blackberries  chocolate  green tea  honey  plums  sesame seeds and sesame oil  soy protein isolate 

Studies

• Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk
• Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer
• Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer
• Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
• Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer
• Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)
• Breast-Cancer Adjuvant Therapy with Zoledronic Acid
• Cancer Therapy Associated Bone Loss: Implications for Hip Fractures in Mid-Life Women with Breast Cancer
• Chocolate consumption and bone density in older women
• Clodronate Appeared Safe, Modestly Affected Breast Cancer Disease Events
• Final 5-year results of Z-FAST trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole
• High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy
• Impaired bone microenvironment: correlation between bone density and presence of disseminated tumor cells
• Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy
• Induced osteoclastogenesis by fluoroquinolones in unstimulated and stimulated human osteoclast precursor cells
• Interaction of sesame seed and tamoxifen on tumor growth and bone health in athymic mice
• Oral Bisphosphonate Did Not Improve Prognosis for Patients With Breast Cancer
• Patient-Reported Predictors of Early Treatment Discontinuation: NCIC JMA.27/E1Z03 Quality of Life Study of Postmenopausal Women with Primary Breast Cancer Randomized to Exemestane or Anastrozole
• Polyphenols, isothiocyanates and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells
• Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice
• Preventive Effects of Zoledronic Acid on Bone Metastasis in Mice Injected with Human Breast Cancer Cells
• Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases
• Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients
• Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms
• Stimulatory effects of extract prepared from the bark of Cinnamomum cassia blume on the function of osteoblastic MC3T3-E1 cells
• The Blackberry Fruit: A Review on Its Composition and Chemistry, Metabolism and Bioavailability, and Health Benefits
• The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study
• The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials
• The Protective Effect of Zoledronic Acid on Bone Loss in Postmenopausal Women with Early Breast Cancer Treated with Sequential Tamoxifen and Letrozole: A Prospective, Randomized, Phase II Trial
• Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE Trial Bone Sub-study
• Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study
• Yerba Mate (Ilex paraguariensis) consumption is associated with higher bone mineral density in postmenopausal women